These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31487529)

  • 1. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
    Mansoor SR; Zabihi E; Ghasemi-Kasman M
    Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.
    El-Akabawy G; Rashed LA
    Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy.
    Giacoppo S; Bramanti P; Mazzon E
    Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):363-379. PubMed ID: 28342084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell transplantation in multiple sclerosis.
    Cohen JA
    J Neurol Sci; 2013 Oct; 333(1-2):43-9. PubMed ID: 23294498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis.
    Shokati A; Naser Moghadasi A; Nikbakht M; Sahraian MA; Mousavi SA; Ai J
    Stem Cell Res Ther; 2021 Jul; 12(1):400. PubMed ID: 34256857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
    Barati S; Tahmasebi F; Faghihi F
    Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
    Rivera FJ; Aigner L
    Biol Res; 2012; 45(3):257-68. PubMed ID: 23283435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
    Harris VK; Vyshkina T; Sadiq SA
    Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
    Karussis D; Kassis I; Kurkalli BG; Slavin S
    J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell Therapy for Multiple Sclerosis.
    Genc B; Bozan HR; Genc S; Genc K
    Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
    Yousefi F; Lavi Arab F; Saeidi K; Amiri H; Mahmoudi M
    J Neuroimmunol; 2019 Mar; 328():20-34. PubMed ID: 30557687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases.
    Uccelli A; Laroni A; Freedman MS
    Lancet Neurol; 2011 Jul; 10(7):649-56. PubMed ID: 21683930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
    Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
    Front Immunol; 2018; 9():2938. PubMed ID: 30619298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis.
    Kråkenes T; Sandvik CE; Ytterdal M; Gavasso S; Evjenth EC; Bø L; Kvistad CE
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
    de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
    Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?
    Uccelli A; Morando S; Bonanno S; Bonanni I; Leonardi A; Mancardi G
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):69-72. PubMed ID: 20955153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.
    Wang X; Kimbrel EA; Ijichi K; Paul D; Lazorchak AS; Chu J; Kouris NA; Yavanian GJ; Lu SJ; Pachter JS; Crocker SJ; Lanza R; Xu RH
    Stem Cell Reports; 2014 Jul; 3(1):115-30. PubMed ID: 25068126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.
    Sargent A; Bai L; Shano G; Karl M; Garrison E; Ranasinghe L; Planchon SM; Cohen J; Miller RH
    Exp Neurol; 2017 Sep; 295():222-232. PubMed ID: 28602834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis.
    Marzban M; Mousavizadeh K; Bakhshayesh M; Vousooghi N; Vakilzadeh G; Torkaman-Boutorabi A
    Iran Biomed J; 2018 Sep; 22(5):312-21. PubMed ID: 29409311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
    Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
    Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.